237 related articles for article (PubMed ID: 17289839)
21. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
22. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate.
Hwa Kim S; Hoon Jeong J; Joe CO; Gwan Park T
J Control Release; 2005 Apr; 103(3):625-34. PubMed ID: 15820409
[TBL] [Abstract][Full Text] [Related]
23. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
[TBL] [Abstract][Full Text] [Related]
24. Folate-targeted non-viral DNA vectors for cancer gene therapy.
Ward CM
Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
[TBL] [Abstract][Full Text] [Related]
25. Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia.
Antohe F; Radulescu L; Puchianu E; Kennedy MD; Low PS; Simionescu M
Cell Tissue Res; 2005 May; 320(2):277-85. PubMed ID: 15714274
[TBL] [Abstract][Full Text] [Related]
26. Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging.
Retnakumari A; Setua S; Menon D; Ravindran P; Muhammed H; Pradeep T; Nair S; Koyakutty M
Nanotechnology; 2010 Feb; 21(5):055103. PubMed ID: 20023317
[TBL] [Abstract][Full Text] [Related]
27. Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells.
Viola-Villegas N; Rabideau AE; Cesnavicious J; Zubieta J; Doyle RP
ChemMedChem; 2008 Sep; 3(9):1387-94. PubMed ID: 18651631
[TBL] [Abstract][Full Text] [Related]
28. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
[TBL] [Abstract][Full Text] [Related]
29. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.
Vlashi E; Sturgis JE; Thomas M; Low PS
Mol Pharm; 2009; 6(6):1868-75. PubMed ID: 19754150
[TBL] [Abstract][Full Text] [Related]
30. [Folate receptor-mediated antitumor drugs].
Zhao J; Cao SL; Zheng XL; Zhao B
Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
[TBL] [Abstract][Full Text] [Related]
31. [Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA].
Zhang Q; Xiang GY; Long N; Lin JL; Zeng FB
Yao Xue Xue Bao; 2005 Nov; 40(11):1046-50. PubMed ID: 16499093
[TBL] [Abstract][Full Text] [Related]
32. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
33. Antifolates targeted specifically to the folate receptor.
Jackman AL; Theti DS; Gibbs DD
Adv Drug Deliv Rev; 2004 Apr; 56(8):1111-25. PubMed ID: 15094210
[TBL] [Abstract][Full Text] [Related]
34. Use of a folate-PPE conjugate to image cancer cells in vitro.
Kim IB; Shin H; Garcia AJ; Bunz UH
Bioconjug Chem; 2007; 18(3):815-20. PubMed ID: 17373773
[TBL] [Abstract][Full Text] [Related]
35. Tumor detection using folate receptor-targeted imaging agents.
Sega EI; Low PS
Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
[TBL] [Abstract][Full Text] [Related]
36. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.
Yang JJ; Kularatne SA; Chen X; Low PS; Wang E
Mol Pharm; 2012 Feb; 9(2):310-7. PubMed ID: 22171616
[TBL] [Abstract][Full Text] [Related]
37. Folate-mediated targeting of therapeutic and imaging agents to cancers.
Reddy JA; Low PS
Crit Rev Ther Drug Carrier Syst; 1998; 15(6):587-627. PubMed ID: 9883391
[TBL] [Abstract][Full Text] [Related]
38. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
[TBL] [Abstract][Full Text] [Related]
39. Stopped-flow kinetic studies of the interaction of bovine folate binding protein (FBP) and folate.
Christensen U; Holm J; Hansen SI
Biosci Rep; 2006 Aug; 26(4):291-9. PubMed ID: 17029005
[TBL] [Abstract][Full Text] [Related]
40. A folate receptor-targeted liposomal formulation for paclitaxel.
Wu J; Liu Q; Lee RJ
Int J Pharm; 2006 Jun; 316(1-2):148-53. PubMed ID: 16564654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
